Clinical Trial Update: A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Perennial Allergic Rhinitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the safety and effectiveness of a nasal spray for perennial allergic rhinitis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• nasal spray (investigational product)

Snippet

Sponsor: Synmosa Biopharma Corp. | Conditions: Allergic Rhinitis | Phase 2 | Status: COMPLETED